# Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.

> **NCT06324942** · NA · RECRUITING · sponsor: **University of Calgary** · enrollment: 80 (estimated)

## Conditions studied

- Cesarean Section Complications
- Pain, Postoperative

## Interventions

- **OTHER:** Surgeon-administered Transversus Abdominis Plane Block 0.25% bupivicaine 0.25 mL/kg

## Key facts

- **NCT ID:** NCT06324942
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-19
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06324942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06324942, "Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06324942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*